Homepage

Everything that a bio-entrepreneur needs, all in one location.

Learn more about Bakar Labs (2:06)

There has never been a shortage of entrepreneurs with great ideas designed to tackle the most pressing global challenges — from human health to environmental sustainability.

To grow those ideas into successful ventures, entrepreneurs need space, equipment, and multiple connections to a vibrant ecosystem. That’s why we created Bakar Bio Labs at UC Berkeley. Bakar Bio Labs is built to be the foundational hub for resources where startups thrive.

A large group of people, photographed from above, look up at the camera, smiling, holding up five fingers.

Five years of innovation at Bakar Labs, and the best is yet to come

UC Berkeley’s world-class incubator for life science and deep tech startups celebrates a major anniversary Read post

Cyclarity Therapeutics Receives FDA Investigational New Drug Clearance for UDP-003 to expand Atherosclerosis Clinical Development Program into the United States

Cyclarity Therapeutics, Inc., a clinical-stage biotechnology company developing cyclodextrin therapeutics to reverse atherosclerotic cardiovascular diseases and metabolic diseases of aging, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for UDP-003. UDP-003, designed by Cyclarity’s proprietary AI-enabled computational platform, is engineered to bind and extract oxidized cholesterol to restore cellular function and spur atherosclerotic plaque regression. Read post
Bakar Labs in numbers
Powered by QB3

Built for startups. For more than 20 years, QB3 has been the University of California’s center for innovation and entrepreneurship in life science. Through pitch summits, seminars, symposia, podcasts, office hours, internships, and workshops QB3 educates, connects, and elevates the entrepreneurial ecosystem.

Learn about QB3
Decorative graphic of QB3 structure